Detalles de la búsqueda
1.
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 103(4): 1187-1196, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291275
2.
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L-ASP: A retrospective analysis with an ASP-based protocol in adult patients with acute lymphoblastic leukaemia.
Br J Haematol
; 201(4): 645-652, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794878
3.
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Eur J Haematol
; 110(6): 618-625, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36732677
4.
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia.
Acta Haematol
; 146(5): 366-372, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315549
5.
Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
Genet Med
; 24(11): 2367-2379, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112138
6.
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study.
Br J Haematol
; 194(3): 557-567, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131896
7.
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.
Haematologica
; 106(1): 56-63, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31896684
8.
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Br J Haematol
; 191(5): 748-754, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395867
9.
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMI.
J Thromb Thrombolysis
; 49(1): 113-120, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31677148
10.
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Haematologica
; 109(2): 671-675, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345484
11.
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms.
Am J Hematol
; 98(4): E88-E90, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36691792
12.
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor.
Am J Hematol
; 98(5): E127-E129, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814403
13.
Prophylaxis with low-molecular-weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase.
Br J Haematol
; 197(2): e32-e34, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994976
14.
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
Br J Haematol
; 179(5): 781-789, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28980314
15.
A t(6;14;9)(p22;q22;q34) three-way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia.
Am J Hematol
; 97(7): 983-985, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292996
16.
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis.
Biol Blood Marrow Transplant
; 22(12): 2270-2275, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27596129
17.
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
Br J Haematol
; 190(3): 467-470, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32567045
18.
Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study.
Intensive Care Med
; 50(2): 222-233, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170226
19.
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Hematology
; 29(1): 2329027, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526239
20.
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.
Bone Marrow Transplant
; 59(2): 196-202, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938736